January 26, 2026
Dear Future Shareholders,
I'm Henri-Dunant CHIKURU, Co-founder and CEO of Helios. Today, I invite you to join us in building something unprecedented: a healthcare revolution that starts in Africa and transforms the world.
This isn't just another tech company. This is a mission to save lives, democratize healthcare, and prove that the next generation of health innovation will come from where it's needed most.
While the world looks elsewhere, Africa is experiencing a healthcare and technology revolution that represents the largest untapped market opportunity of our generation.
$139.96B
Market size in 2024
$227.09B
Projected by 2030
8.4% CAGR
62% growth over 6 years
Source: Mordor Intelligence - Africa Healthcare Market Report
$3.8B
Digital health market in 2023
23.4% CAGR
Growing to 2030 - fastest in the world
73%
of diabetes cases in Africa are undiagnosed - the highest rate in the world
38%
internet penetration - massive room for growth
28%
mobile internet penetration - but growing rapidly
Sources: International Diabetes Federation, GSMA Mobile Economy
Artificial Intelligence is transforming healthcare globally, and Africa is positioned to leapfrog traditional healthcare infrastructure.
$36.96B
2025
$613.81B
2034
36.83%
CAGR
1,560% growth in 9 years
$6.85B
2025
$21.47B
2031
20.8%
CAGR
Africa's AI healthcare market is growing at 20.8% annually - proving the continent is ready for intelligent health solutions.
We're not just building wearables. We're building the future of how humans interact with health technology.
$5.16B
2024
$21.48B
2030
26.2%
CAGR
$45.29B
2025
$75.98B
2030
10.9%
CAGR
Africa is already a global leader in mobile payments. We're building on that foundation to create the world's most advanced health payment ecosystem.
$1.1T
Mobile payments processed in Africa (2024)
Africa processes more mobile payments than any other continent. We're integrating health data with this existing infrastructure.
Source: GSMA Mobile Economy Report
$781.72M
2023
$1.54B
2031
8.8%
CAGR
Source: Allied Market Research - Africa Contactless Payments
$1.02B
2024
$2.84B
2032
13.7%
CAGR
$21.69B
2024
$30.55B
2029
7.1%
CAGR
Our Health Cards use NFC technology to provide instant access to medical records, emergency information, and payment capabilities - all in one tap.
Source: Markets and Markets - NFC Market
We're starting in Uganda - a country with explosive economic growth, a young population, and a government committed to digital transformation.
6.1%
GDP Growth 2023/24
6.3%
Projected 2024/25
10.4%
Projected 2027 (with oil)
Per capita income: $1,263 (2024/25) and rising rapidly
$134.10M
2024
$208.00M
2029
9.18%
CAGR
$36.38M
2024
$59.27M
2029
10.25%
CAGR
Uganda's fitness tracker market is growing faster than the global average - proving demand for health technology exists and is accelerating.
$16.8B
2025
$23.6B
2034
3.90%
CAGR
We're not building individual products. We're building an integrated ecosystem that works together seamlessly.
Fabric-integrated sensors that monitor heart rate, respiration, temperature, and movement. Washable, comfortable, invisible.
Medical-grade watches and bands with advanced biosensors. ECG, SpO2, blood pressure, glucose monitoring.
NFC-enabled card with encrypted medical records, emergency contacts, allergies, medications. Works offline.
Integrated payment system for healthcare services. Mobile money integration, insurance claims, medication purchases.
Each product works independently. But together, they create an unprecedented health monitoring and management system. Your smart clothing detects an anomaly. Your wearable confirms it. Your health card has your medical history ready. Your digital wallet pays for the ambulance. All in seconds.
We're entering multiple markets at their inflection points:
Hardware Sales
Smart clothing, wearables, health cards
Subscription Services
Premium AI analytics, cloud storage, telemedicine
B2B Partnerships
Hospitals, insurance companies, corporate wellness
Transaction Fees
Digital wallet payments, insurance claims processing
In 5 years, we see Helios as the leading health technology company in East Africa, with millions of users across Uganda, Kenya, Tanzania, Rwanda, and beyond.
In 10 years, we see Helios as a global brand that started in Africa and proved that the next generation of healthcare innovation comes from emerging markets.
We see a world where:
This isn't a dream. This is our roadmap.
We're not just asking for investment. We're inviting you to be part of a movement that will transform healthcare for billions of people.
The data is clear. The market is ready. The technology is proven. The team is committed.
All we need is partners who believe in our vision.
investors@helioshealths.com
The future of healthcare won't be built in Silicon Valley or London or Shanghai.
It will be built where it's needed most. Where innovation meets necessity. Where technology meets humanity.
It will be built in Africa.
And it starts with Helios.
Thank you for considering this opportunity.
I look forward to building the future together.
Sincerely,

Henri-Dunant CHIKURU
Co-founder and CEO, Helios Technologies Ltd.
January 26, 2026
INSTITUTIONS
All market data and statistics cited in this letter are from publicly available reports and research published between 2024-2026. Links open in new tabs for verification.
This letter contains "forward-looking statements" including statements regarding Helios's financial outlook, product development timelines for our Health Plus ecosystem (smart clothing, smart wearables, health cards, and digital wallets), market expansion plans in Africa, expected benefits of our AI-powered health monitoring platforms, business strategy, partnerships with healthcare providers and insurance companies, revenue projections, market size estimates, and growth opportunities in African healthcare markets.
These forward-looking statements are based on current expectations, market research, and management assumptions as of January 26, 2026. Words such as "will," "see," "vision," "expect," "plan," "project," "believe," "potential," and similar expressions identify these statements. Actual results may differ materially due to factors including: our ability to execute our Africa-first strategy; regulatory approvals for medical devices in target markets; adoption rates of health technology in emerging markets; competition from established global health tech companies; our ability to secure adequate funding; challenges in manufacturing and distributing hardware products; healthcare infrastructure limitations in African markets; currency fluctuations; data privacy regulations; cybersecurity risks; our ability to maintain ISO 13485 and CE certifications; partnerships with local healthcare providers; macroeconomic conditions in Africa; and technological challenges in AI development.
Market data cited from third-party sources (Mordor Intelligence, Grand View Research, Statista, GSMA, World Bank, etc.) represents estimates and forecasts that involve assumptions and limitations. We have not independently verified this data and make no representations regarding its accuracy. These projections should not be relied upon as guarantees of future market conditions or our performance.
This letter represents our views as of January 26, 2026. We undertake no obligation to update these statements. Past performance and market trends are not indicative of future results. Prospective investors should conduct their own due diligence and analysis before making investment decisions.